Katsin M reported a patient with stage IV primary mediastinal B-cell lymphoma who received methotrexate, cytarabine, and dexamethasone as first-line treatment for CD19 CAR-T cell related grade IV ICANS. The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.